Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to show the effectiveness of repeated doses of COV795
versus placebo, using the summed pain intensity difference over the first 48 hours in
subjects with acute moderate to severe pain following bunionectomy.